FDA Alerts
OK for New Asthma Rx
The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older.
FDA Adds Important Safety Information to Xolair Label
An FDA review of safety studies suggests a slightly increased risk of problems involving the heart and blood vessels supplying the brain among patients being treated with the asthma drug Xolair (omalizumab) than in those who were not treated with Xolair.
FDA Approves Generic Singulair
The US Food and Drug Administration approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.
Inhaler Discontinued to Save the Planet
As part of an international agreement to discontinue the use of chlorofluorocarbons that damage the environment, a leading over-the-counter asthma inhaler will not be available next year.